Volume 12, Issue 3 (Paramedical Sciences and Military Health (Autumn 2017) 2017)                   Paramedical Sciences and Military Health 2017, 12(3): 17-22 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Jalallou N, Meamar A R. Frequency of Blastocystis among Malignant Patients in Comparison with Control Group. Paramedical Sciences and Military Health. 2017; 12 (3) :17-22
URL: http://jps.ajaums.ac.ir/article-1-128-en.html
1- Department of Medical Laboratory Sciences, Faculty of Para medicine, AJA University of Medical Sciences, Tehran, Iran , N.jalallou@ajaums.ac.ir
2- Department of Parasitology and Mycology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
Abstract:   (463 Views)
Introduction: Blastocystis is one of the most common intestinal parasites of humans and many animals. It has a worldwide distribution. The probability of clinical manifestation has been increased among Immunocompromised patients such as those receiving chemotherapy or patients with malignancy. However, infection is often asymptomatic or self-limited in healthy individuals. The present study aimed to investigate the frequency of Blastocystis among patients with different kinds of malignancy compared to the control group in Eman Reza hospital.
Methods and Materials: This cross-sectional study has been performed from June 2012 to July 2013. A total 116 stool samples were obtained from hospitalized malignant patients. Moreover, 83 stool samples were collected from patients of hospital laboratory as a control group. The characteristics of stool samples including color and appearances were recorded. Stool samples were examined directly by wet mount preparation using the saline and iodine method. Moreover, samples were examined by formalin-ether concentration. Data were analyzed using Chi-squared test by SPSS version 17.
Results: A total 199 stool samples were collected and examined in both case and control groups. The frequency of Blastocystis spp was 17 (14.7%) in the case group that 14 of these samples (19.2%) were related to cancerous patients and 3 samples of them were those having leukemia. There were statistically significant differences between the frequency of Blastocystis in both groups (p=0.100).
Discussion and Conclusion: Those patients receiving chemotherapy must be screened for infections such as Blastocystis to prevent possible life threatening outcome. Further studies are necessary to distinguish the subtypes of Blastocystis.
Full-Text [PDF 1789 kb]   (118 Downloads)    
Type of Study: Research | Subject: full articles
Received: 2017/11/28 | Accepted: 2017/12/15 | Published: 2017/12/20

Add your comments about this article : Your username or Email:
Write the security code in the box

Send email to the article author


© 2015 All Rights Reserved | Paramedical Sciences and Military Health